Endotelix is a privately held Swiss biotech start-up company and a spin-off from the University of Geneva. Endotelix is dedicated to providing fast, sensitive and reliable solutions for Antiphospholipid Syndrome, including diagnostic tests and therapies.
Company Details
- Founded
- 2019
- Address
- Avenue De La Roseraie 64, Genève,genève 1205,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.endotelix.com
- Keywords
- diagnostics, Biotech, APS, LFA.
- HQ
- Genève, Genève
Endotelix Diagnostics Ltd Questions
Endotelix Diagnostics Ltd's website is http://www.endotelix.com
Endotelix Diagnostics Ltd's LinkedIn profile is https://ch.linkedin.com/company/endotelix-diagnostics-ltd
Endotelix Diagnostics Ltd's industry is
Biotechnology Research
Endotelix Diagnostics Ltd's top competitors are
Episkin Sa,
Sun Bioscience,
Plateforme Biopark D'archamps,
Selexis Sa,
Vitrocell Systems Gmbh,
Altertox,
Epithelix,
Leman Biotech,
Fluosphera,
Adiposs.
Endotelix Diagnostics Ltd's categories are Biotechnology Research
Endotelix Diagnostics Ltd's founding year is 2019
